Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov 27:10:2769.
doi: 10.3389/fimmu.2019.02769. eCollection 2019.

The Evolution of T Cell Depleted Haploidentical Transplantation

Franco Aversa  1 , Antonio Pierini  2 , Loredana Ruggeri  2 , Massimo Fabrizio Martelli  2 , Andrea Velardi  2
Affiliations
Review

The Evolution of T Cell Depleted Haploidentical Transplantation

Franco Aversa et al. Front Immunol. .

Abstract

Work on bone marrow transplantation from haploidentical donor has been proceeding for over 20 years all over the world and new transplant procedures have been developed. To control both graft rejection and graft vs. host disease, some centers have preferred to enhance the intensity of the conditioning regimens and the post-transplant immune suppression in the absence of graft manipulation; others have concentrated on manipulating the graft in the absence of any additional post-transplant immune suppressive agent. Due to the current high engraftment rates, the low incidence of graft-vs.-host disease and regimen related mortality, transplantation from haploidentical donors have been progressively offered even to elderly patients. Overall, survivals compare favorably with reports on transplants from unrelated donors. Further improvements will come with successful implementation of strategies to enhance post-transplant immune reconstitution and to prevent leukemia relapse.

Keywords: T cell depletion; graft vs. host disease; graft vs. leukemia effect; haploidentical transplantation; immune reconstitution.

PubMed Disclaimer

References

    1. Apperley J, Niederwieser D, Huang XJ, Nagler A, Fuchs E, Szer J, et al. Haploidentical hematopoietic stem cell transplantation: a global overview comparing Asia, the European Union, and the United States. Biol Blood Marrow Transplant. (2016) 22(3 Suppl):S15–8. 10.1016/j.bbmt.2016.01.006 - DOI - PubMed
    1. Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. . Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant. (2017) 52:811–7. 10.1038/bmt.2017.34 - DOI - PMC - PubMed
    1. Sun Y, Beohou E, Labopin M, Volin L, Milpied N, Yakoub-Agha I, et al. . Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database. Haematologica. (2016) 101:e352–4. 10.3324/haematol.2015.140509 - DOI - PMC - PubMed
    1. Bertaina A, Zecca M, Buldini B, Sacchi N, Algeri M, Saglio F, et al. . Unrelated donor vs HLA-haploidentical α/β T-cell- and B-cell-depleted HSCT in children with acute leukemia. Blood. (2018) 132:2594–607. 10.1182/blood-2018-07-861575 - DOI - PubMed
    1. Ruggeri A, Labopin M, Sanz G, Piemontese S, Arcese W, Bacigalupo A, et al. . Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia. (2015) 29:1891–900. 10.1038/leu.2015.98 - DOI - PubMed

Publication types